Patrick Soon-Shiong & cancer moonshot 2020

is this the ace up his sleeve? Benitec said they would follow up on bb-401 and the trial is still ongoing according to clinicaltrials.org.

Soon-Shiong also said his company's work in cancer therapies was "bearing fruit," and he plans to announce research detailing an approach to "induce immunogenic cell death in patients with cancer" in the next few months.Soon-Shiong said the company will have "exciting data" to share in the next few months regarding cancer therapeutics for "triple negative breast cancer, bladder cancer, and neck and head cancer," he said.Biotech billionaire Soon-Shiong steps down from ONC health IT advisory committee

https://www.fiercehealthcare.com/tech/biotech-billionaire-peter-soon-shiong-steps-down-from-onc-health-it-advisory-committee